1. Home
  2. RC vs KROS Comparison

RC vs KROS Comparison

Compare RC & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ready Capital Corproation

RC

Ready Capital Corproation

HOLD

Current Price

$1.10

Market Cap

272.6M

Sector

Real Estate

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

SELL

Current Price

$10.77

Market Cap

222.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
RC
KROS
Founded
2007
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
272.6M
222.7M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
RC
KROS
Price
$1.10
$10.77
Analyst Decision
Hold
Buy
Analyst Count
7
7
Target Price
$1.50
★ $19.83
AVG Volume (30 Days)
★ 1.7M
169.6K
Earning Date
11-05-2026
11-04-2026
Dividend Yield
★ 3.57%
N/A
EPS Growth
45.25
★ 146.00
EPS
★ N/A
N/A
Revenue
N/A
★ $243,864,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.06
$9.69
52 Week High
$3.26
$22.55

Technical Indicators

Market Signals
Indicator
RC
KROS
Relative Strength Index (RSI) 35.65 42.58
Support Level $1.08 $10.65
Resistance Level $1.88 $11.86
Average True Range (ATR) 0.08 0.50
MACD 0.00 -0.08
Stochastic Oscillator 22.41 6.92

Price Performance

Historical Comparison
RC
KROS

About RC Ready Capital Corproation

Ready Capital Corp is a real estate finance company that originates, acquires, finances, and services LMM loans, SBA loans, construction loans, USDA loans and, to a lesser extent, MBS collateralized mainly by LMM loans or other real estate-related investments. Its loans are used by businesses to purchase real estate used in their operations or by investors seeking to acquire multi-family, office, retail, mixed use or warehouse properties. It operates through two segments: LMM Commercial Real Estate, which originates LMM loans across the life-cycle of an LMM property including construction, bridge, stabilized and agency loan channels, and Small Business Lending, which acquires, originates and services owner-occupied loans guaranteed by the SBA and also originates and services USDA loans.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: